Vaccination coverage in rural Burkina Faso under the effects of COVID-19: evidence from a panel study in eight districts.

Vaccination coverage in rural Burkina Faso under the effects of COVID-19: evidence from a panel study in eight districts.

Publication date: Sep 21, 2023

Improving infant immunization completion and promoting equitable vaccination coverage are crucial to reducing global under-5 childhood mortality. Although there have been hypotheses that the impact of the COVID-19 pandemic would decrease the delivery of health services and immunization campaigns in low- and middle-income countries, the available evidence is still inconclusive. We conducted a study in rural Burkina Faso to assess changes in vaccination coverage during the pandemic. A secondary objective was to examine long-term trends in vaccination coverage throughout 2010-2021. Using a quasi-experimental approach, we conducted three rounds of surveys (2019, 2020, 2021) in rural Burkina Faso that we pooled with two previous rounds of demographic and household surveys (2010, 2015) to assess trends in vaccination coverage. The study population comprised infants aged 0-13 months from a sample of 325 households randomly selected in eight districts (nā€‰=ā€‰736). We assessed vaccination coverage by directly observing the infants’ vaccination booklet. Effects of the pandemic on infant vaccination completion were analyzed using multi-level logistic regression models with random intercepts at the household and district levels. A total of 736 child-year observations were included in the analysis. The proportion of children with age-appropriate complete vaccination was 69. 76% in 2010, 55. 38% in 2015, 50. 47% in 2019-2020, and 64. 75% in 2021. Analyses assessing changes in age-appropriate full-vaccination coverage before and during the pandemic show a significant increase (OR: 1. 8, 95% CI: 1. 14-2. 85). Our models also confirmed the presence of heterogeneity in full vaccination between health administrative districts. The pandemic could have increased inequities in infant vaccination completion between these districts. The analyses suggest no disruption in age-appropriate full vaccination due to COVID-19. Our findings from our sensitivity analyses to examine trends since 2010 did not show any steady trends. Our findings in Burkina Faso do not support the predicted detrimental effects of COVID-19 on the immunization schedule for infants in low- and middle-income countries. Analyses comparing 2019 and 2021 show an improvement in age-appropriate full vaccination. Regardless of achieving and sustaining vaccination coverage levels in Burkina Faso, this should remain a priority for health systems and political agendas.

Open Access PDF

Concepts Keywords
Pandemic Burkina Faso
Rural Children
Vaccination COVID19
Routine vaccination
Vaccination coverage


Type Source Name
disease VO vaccination coverage
disease MESH COVID-19
disease VO immunization
disease VO population
disease VO vaccination
pathway REACTOME Reproduction
disease VO organization
disease MESH measles
pathway KEGG Measles
disease MESH vaccine preventable diseases
disease MESH poliomyelitis
disease MESH diphtheria
disease VO vaccinated
drug DRUGBANK Coenzyme M
disease IDO country
disease IDO history
disease VO protocol
disease VO vaccine
drug DRUGBANK Trestolone
disease VO immunized
disease MESH tetanus
disease MESH pertussis
pathway KEGG Pertussis
disease MESH hepatitis
disease VO Rotavirus
drug DRUGBANK Yellow Fever Vaccine
drug DRUGBANK BCG vaccine
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Cysteamine
disease IDO site
disease VO report
disease VO inefficient
disease VO Gap
disease VO effective
disease MESH emergencies
drug DRUGBANK Clostridium tetani toxoid antigen (formaldehyde inactivated)
disease VO Canada
disease VO USA
disease MESH unwanted pregnancies
disease VO organ
disease IDO facility
disease MESH scar
drug DRUGBANK Silver
disease VO influenza vaccines
disease VO Equity
drug DRUGBANK Rotavirus Vaccine
disease VO Rotavirus vaccine
disease VO effectiveness
disease VO conjugate vaccine

Original Article

(Visited 1 times, 1 visits today)